-0.76 | -2.40%
| Price and Volume | |
|---|---|
| Recent Price | 31.65 |
| 52 Week High | 38.07 |
| 52 Week Low | 27.84 |
| Avg. Daily Vol. (Mil) | 0.84 |
| Beta (3 year) | 0.69 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,856.92 |
| Shares Out (Mil) | 58.67 |
| Float (Mil) | 58.47 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 6.00 |
| Current Ratio | 7.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 23.60 |
| Price/Sales | 4.13 |
| Price/Book | 3.01 |
| Price/Cash Flow | 18.20 |
| Per Share Data | |
| Earnings | 1.34 |
| Sales | 7.67 |
| Book Value | 10.51 |
| Cash Flow | 1.74 |
| Business Summary | |
|---|---|
| Thoratec Laboratories Corporation develops, manufactures and markets proprietary medical devices used for circulatory support. | |
| General Information | |
| 6035 Stoneridge Drive
Pleasanton, CA 94588 |
|
| www.thoratec.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 773 | |
| CEO: Mr. Gerhard F. Burbach | |
| Short Interest | |
| Current Month (Mil) | 2.42 |
| Previous Month (Mil) | 1.40 |
| Short Interest Ratio (Days) | 2.50 |
| Management Effectiveness | |
| Return on Equity | 13.10 |
| Return on Assets | 11.30 |
| Return on Investments | 13.10 |
| Profitability | |
| Gross Margin | 73.30 |
| EBIT Margin | 28.10 |
| Profit Margin | 17.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
102.98
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet